Skip to main content
GI Innovation Inc. logo

GI Innovation Inc. — Investor Relations & Filings

Ticker · 358570 ISIN · KR7358570000 KO Professional, scientific and technical activities
Open in API
Filings indexed 352 across all filing types
Latest filing 2026-06-08 Regulatory Filings
Country KR South Korea
Listing KO 358570

About GI Innovation Inc.

https://www.gi-innovation.com/en/

GI Innovation Inc. is a bio-venture company that researches and develops innovative protein-based drugs. The company utilizes its proprietary GI-SMART™ platform to create novel biologics, focusing on immuno-oncology and immunology-related diseases. Its development pipeline includes key candidates such as GI-101, an immuno-oncology treatment, and GI-301 for IgE-mediated allergic diseases. The company's approach is guided by its 'Science, Strategy, Speed' (3S) strategy, which integrates basic science with translational research to accelerate drug development.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(임상시험계획변경승인신청) (진행성 또는 전이성 고형암 시험대상자를 대상으로 GI108 단일 요법의 안전성, 내약성, 약동학 및 치료효과를 평가하기 위한 제1/2a상 임상시험 계획 변경승인신청)
Regulatory Filings Classification · 80% confidence The document is a Korean regulatory disclosure titled “투자판단 관련 주요경영사항” concerning an application for approval to change a clinical trial plan submitted to the MFDS. It provides detailed business-event information for investors but does not constitute a full financial report, earnings release, dividend notice, or any other specialized filing category. It is a general regulatory announcement, so it falls under the fallback category Regulatory Filings (RNS).
2026-06-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a ‘주식등의 대량보유상황보고서’, a statutory report under Korea’s Capital Markets Act detailing a large shareholding position, changes in holdings by a major shareholder and related parties, including percentages and transaction details. This aligns exactly with a Major Shareholding Notification.
2026-06-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a securities ownership status report filed by an officer/major shareholder (“임원ㆍ주요주주 특정증권등 소유상황보고서”) with details of share holdings and changes, conforming to insider transaction disclosure requirements. This matches the definition of a Director’s Dealing report (insider trades by directors/executives).
2026-06-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 96% confidence The document is a statutory report filed with the Securities and Futures Commission and Korea Exchange disclosing an officer’s (“임원”) ownership and changes in specific securities (“특정증권등 소유상황보고서”). It itemizes the number of shares owned, changes in holdings, and transaction details by a company executive. This matches the definition of insider transactions by directors and executives (Director's Dealing).
2026-06-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a Korean ‘임원ㆍ주요주주 특정증권등 소유상황보고서’ which details an officer’s personal shareholdings and changes (stock option exercises, share acquisitions) by an executive (부사장 조영규). This is clearly an insider transaction filing by a director/executive reporting his own securities trades. Therefore, it fits the Director’s Dealing category (DIRS).
2026-06-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 98% confidence The document is a Korean insider disclosure form titled “임원ㆍ주요주주 특정증권등 소유상황보고서” detailing the share ownership and changes for a company director (김제이) at GI Innovation, including specific securities counts, percentages, transaction dates, and price info. This matches an insider director’s dealing report rather than a financial report, governance policy, or meeting material.
2026-06-05 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.